PHIO · Phio Pharmaceuticals Corp.
$1.13
+0.01 (+0.89%)
At close · Aug 28
Going-concern doubt
— cleared Aug 6, 2026
The latest filing states the doubt was alleviated.
“The Company has limited cash resources, has incurred recurring operating losses and negative cash flows from its operations since its inception and has not yet recognized any product revenues. These factors have previously raised doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 6, 2026
Market Cap
$13.13M
Shares
11.62M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding PHIO
7 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND | — | 94,262 | $96,619 | 0.00% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 80,599 | $89,465 | 0.00% | Long | 2026-05-31 | |
| Nomura Healthcare Fund | — | 50,000 | $51,250 | 0.01% | Long | 2026-06-30 | |
| Fidelity Series Total Market Index Fund | FCFMX | 14,664 | $16,277 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | FSKAX | 13,285 | $14,746 | 0.00% | Long | 2026-05-31 | |
| Ultra-Small Company Fund | BRUSX | 12,000 | $12,300 | 0.01% | Long | 2026-06-30 | |
| Blackstone Alternative Multi-Strategy Fund | — | 4 | $4 | 0.00% | Long | 2026-06-30 |
Showing 1–7 of 7 positions